Crinetics Pharmaceuticals, Inc. (CRNX) Capital expenditures 2016–2025
Crinetics Pharmaceuticals, Inc. (CRNX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$5.8MFY2025 · since FY2016: $190,000 → $5.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.8M | +49.9% |
| FY2024 | $3.8M | -18.0% |
| FY2023 | $4.7M | +183.1% |
| FY2022 | $1.7M | +279.8% |
| FY2021 | $436,000 | +134.4% |
| FY2020 | $186,000 | -62.2% |
| FY2019 | $492,000 | -53.5% |
| FY2018 | $1.1M | +248.4% |
| FY2017 | $304,000 | +60.0% |
| FY2016 | $190,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice